The gateway to the largest hospital in Catalonia.
The gateway to research and medical innovation.
The gateway to the oncology center of excellence.
The space for specialized and top-level care of the multiple sclerosis.
We are Vall d'Hebron
Activate and deactivate items in the key to see those that interest you.
Use the list to answer your health-related questions.
Learn more about cancer. Find out about the risk factors and specialist care we provide.
We make life easier. We can help with all administrative processes and get you the information you need during your time in hospital and...
Donate your time through a voluntary organisation or tell us about your experience at the hospital.
If you are considering where to do your residency, we can offer a wide range of clinical specialisations when you train at Vall d’Hebron...
Last year, the hospital performed 114 cornea transplants, beating its own record. The Ophthalmology Department offers all available...
Maria Salvado has worked in the Vall d’Hebron Research Institute and the Neurology Department at Hospital Universitari Vall d’Hebron in Barcelona since 2012, where his clinical work focuses on treatment of neuromuscular disorders.
She works as neurologist at the Neuromuscular and Rare Diseases Unit of the Neurology Department at Hospital Universitari Vall d’Hebron and as a clinical researcher at the Peripheral Nervous System Laboratory coordinated by Dr. J. Gamez at the Vall d'Hebron Research Institute. The main research lines of this research group in which she is working on are based on genetic biomarkers and determinants of familial ALS, autoimmune myasthenia gravis and inherited myopathies and neuropathies. She is also one of the professionals working for the European Reference Network in Neuromuscular and rares diseases (EURO-NMD ERN) and the European Reference Network in rare neurological diseases (EURO-RND). Hospital Vall d’Hebron is member of these ERNs. She has co-authored about 18 peer-rewieved articles and is now working on her doctoral programme. In 2013, she was awarded with the Scientific Poster Award in the International Symposium for ALS (MNDA). She is co-investigator for several grants and clinical trials, including FIS (Fondo de Investigación Sanitarias) and MINECO (Ministerio de Economía y Competitividad) grants. These grants are for studies of rare disorders such as ALS, myasthenia gravis, familial amyloid polyneuropathy (Corino-Andrade's disease), mitochondrial disorders and chronic inflammatory demyelinating polyneuropathy (CIDP).